← MIMEDX GROUP, INC. MDXG
Market Price
$4.29
Market Cap
$624.08M
P/E Ratio
13.39
Revenue (FY 2025)
↑20.0% YoY
$418.63M
3-Yr CAGR: 16.1%
Net Income
↑14.5% YoY
$48.58M
Net Margin: 11.6%
Free Cash Flow
↑13.1% YoY
$72.97M
FCF Yield: 11.69%
EPS (Diluted)
↑14.3% YoY
$0.32
Basic: $0.33
Return on Equity
Efficiency
18.9%
ROA: 17.5%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (MDXG)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $245.0M | — | $212.6M | $12.0M | — | $0.11 | — | $25.8M | $19.6M | — |
| FY 2017 | $321.1M | +31.1% | $285.9M | $64.7M | +440.6% | $0.56 | +409.1% | $62.9M | $57.8M | +195.6% |
| FY 2018 | $359.1M | +11.8% | $322.7M | $-30.0M | -146.3% | $-0.28 | -150.0% | $35.8M | $26.4M | -54.4% |
| FY 2019 | $299.3M | -16.7% | $256.2M | $-25.6M | +14.7% | $-0.24 | +14.3% | $-39.4M | $-41.2M | -256.1% |
| FY 2020 | $248.2M | -17.0% | $208.9M | $-49.3M | -92.7% | $-0.77 | -220.8% | $-30.3M | $-34.5M | +16.2% |
| FY 2021 | $258.6M | +4.2% | $215.3M | $-10.3M | +79.1% | $-0.15 | +80.5% | $-2.0M | $-5.2M | +84.9% |
| FY 2022 | $267.8M | +3.6% | $219.5M | $-30.2M | -193.6% | $-0.33 | -120.0% | $-17.9M | $-19.4M | -273.2% |
| FY 2023 | $321.5M | +20.0% | $266.8M | $58.2M | +292.8% | $0.37 | +212.1% | $26.8M | $24.8M | +227.7% |
| FY 2024 | $348.9M | +8.5% | $288.8M | $42.4M | -27.2% | $0.28 | -24.3% | $66.2M | $64.5M | +160.3% |
| FY 2025 | $418.6M | +20.0% | $345.6M | $48.6M | +14.5% | $0.32 | +14.3% | $74.0M | $73.0M | +13.1% |
Valuation
Market Price
$4.29
Market Cap
$624.08M
Enterprise Value
$475.93M
P/E Ratio
13.39
P/B Ratio
2.49
FCF Yield
11.69%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
82.56%
Operating Margin
15.26%
Net Margin
11.60%
Return on Equity (ROE)
18.94%
Return on Assets (ROA)
17.51%
Asset Turnover
1.51x
Revenue 3-Yr CAGR
16.05%
Financial Health & Liquidity
Current Ratio
24.38
Cash Ratio
14.59
Debt / Equity
0.070
Debt / Assets
0.065
Cash & Equivalents
$166.12M
Total Debt
$17.97M
Book Value / Share
$1.72
Cash Flow Efficiency
Operating Cash Flow
$74.00M
Capital Expenditures (CapEx)
$1.03M
Free Cash Flow
$72.97M
OCF / Revenue
17.68%
FCF / Revenue
17.43%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$0.32
EPS (Basic)
$0.33
Dividends / Share
N/A
Book Value / Share
$1.72
EPS YoY Growth
14.29%
Balance Sheet (FY 2025)
Total Assets
$277.47M
Total Liabilities
$11.38M
Stockholders' Equity
$256.55M
Current Assets
$277.47M
Current Liabilities
$11.38M